SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Melissa A. Martinez, Raj Vuppalanchi, Robert J. Fontana, Andrew Stolz, David E. Kleiner, Paul H. Hayashi, Jiezhun Gu, Jay H. Hoofnagle, Naga Chalasani, Clinical and Histologic Features of Azithromycin-Induced Liver Injury, Clinical Gastroenterology and Hepatology, 2015, 13, 2, 369

    CrossRef

  2. 2
    D. M. Foureau, T. L. Walling, V. Maddukuri, W. Anderson, K. Culbreath, D. E. Kleiner, W. A. Ahrens, C. Jacobs, P. B. Watkins, R. J. Fontana, N. Chalasani, J. Talwalkar, W. M. Lee, A. Stolz, J. Serrano, H. L. Bonkovsky, Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis, Clinical & Experimental Immunology, 2015, 180, 1
  3. 3
    Mala Chakraborty, Aaron M. Fullerton, Kenrick Semple, Lynette S. Chea, William R. Proctor, Mohammed Bourdi, David E. Kleiner, Xiangbin Zeng, Pauline M. Ryan, Pradeep K. Dagur, Julia D. Berkson, Timothy P. Reilly, Lance R. Pohl, Drug-induced allergic hepatitis developed in mice when myeloid-derived suppressor cells were depleted prior to halothane treatment, Hepatology, 2015, 61, 4
  4. 4
    Rongtao Lai, Xiaogang Xiang, Ruidong Mo, Rebecca Bao, Peng Wang, Simin Guo, Gangde Zhao, Honglian Gui, Hui Wang, Shisan Bao, Qing Xie, Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury, Journal of Hepatology, 2015,

    CrossRef

  5. 5
    Naga P Chalasani, Paul H Hayashi, Herbert L Bonkovsky, Victor J Navarro, William M Lee, Robert J Fontana, ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury, The American Journal of Gastroenterology, 2014, 109, 7, 950

    CrossRef

  6. You have free access to this content6
    James H. Lewis, Causality assessment: Which is best—expert opinion or RUCAM?, Clinical Liver Disease, 2014, 4, 1
  7. 7
    James H. Lewis, Drug-Induced Liver Injury, Dosage, and Drug Disposition: Is Idiosyncrasy Really Unpredictable?, Clinical Gastroenterology and Hepatology, 2014, 12, 9, 1556

    CrossRef

  8. 8
    Walid M Chalhoub, Kayla D Sliman, Meera Arumuganathan, James H Lewis, Drug-induced liver injury: what was new in 2013?, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 7, 959

    CrossRef

  9. 9
    Qi Miao, Zhaolian Bian, Ruqi Tang, Haiyan Zhang, Qixia Wang, Shanshan Huang, Xiao Xiao, Li Shen, Dekai Qiu, Edward L. Krawitt, M. Eric Gershwin, Xiong Ma, Emperipolesis Mediated by CD8 T Cells Is a Characteristic Histopathologic Feature of Autoimmune Hepatitis, Clinical Reviews in Allergy & Immunology, 2014,

    CrossRef

  10. 10
    John R. Senior, Evolution of the Food and Drug Administration Approach to Liver Safety Assessment for New Drugs: Current Status and Challenges, Drug Safety, 2014, 37, S1, 9

    CrossRef

  11. 11
    Sara La Gioia, Giuseppe Bacis, Aurelio Sonzogni, Barbara Frigeni, Marta Zaffira Conti, Marcella Vedovello, Mariarosa Rottoli, Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis, Multiple Sclerosis and Related Disorders, 2014, 3, 6, 732

    CrossRef

  12. You have free access to this content12
    David E. Kleiner, Liver histology in the diagnosis and prognosis of drug-induced liver injury, Clinical Liver Disease, 2014, 4, 1
  13. 13
    Camilla Stephens, Raúl J. Andrade, M. Isabel Lucena, Mechanisms of drug-induced liver injury, Current Opinion in Allergy and Clinical Immunology, 2014, 14, 4, 286

    CrossRef

  14. 14
    Robert J. Fontana, Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives, Gastroenterology, 2014, 146, 4, 914

    CrossRef

  15. 15
    Mark W. Russo, Jay H. Hoofnagle, Jiezhun Gu, Robert J. Fontana, Huiman Barnhart, David E. Kleiner, Naga Chalasani, Herbert L. Bonkovsky, Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network, Hepatology, 2014, 60, 2